408 related articles for article (PubMed ID: 15756580)
41. Microperimetric changes after intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion.
Senturk F; Ozdemir H; Karacorlu M; Karacorlu SA; Uysal O
Retina; 2010 Sep; 30(8):1254-61. PubMed ID: 20827142
[TBL] [Abstract][Full Text] [Related]
42. Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion.
Goff MJ; Jumper JM; Yang SS; Fu AD; Johnson RN; McDonald HR; Ai E
Retina; 2006 Oct; 26(8):896-901. PubMed ID: 17031289
[TBL] [Abstract][Full Text] [Related]
43. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial.
Sutter FK; Simpson JM; Gillies MC
Ophthalmology; 2004 Nov; 111(11):2044-9. PubMed ID: 15522370
[TBL] [Abstract][Full Text] [Related]
44. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
Spaide RF; Sorenson J; Maranan L
Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166
[TBL] [Abstract][Full Text] [Related]
45. Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.
Sivaprasad S; Ockrim Z; Massaoutis P; Ikeji F; Hykin PG; Gregor ZJ
Retina; 2008; 28(10):1435-42. PubMed ID: 18628722
[TBL] [Abstract][Full Text] [Related]
46. Intravitreal triamcinolone versus intravitreal bevacizumab in the treatment of exudative retinal detachment secondary to posterior uveal melanoma.
Parrozzani R; Pilotto E; Dario A; Miglionico G; Midena E
Am J Ophthalmol; 2013 Jan; 155(1):127-133.e2. PubMed ID: 22995029
[TBL] [Abstract][Full Text] [Related]
47. Indocyanine green-mediated photothrombosis with intravitreal triamcinolone acetonide for subfoveal choroidal neovascularization in age-related macular degeneration.
Arevalo JF; Garcia RA; Mendoza AJ
Graefes Arch Clin Exp Ophthalmol; 2005 Nov; 243(11):1180-5. PubMed ID: 15906068
[TBL] [Abstract][Full Text] [Related]
48. Combined intravitreal bevacizumab and triamcinolone in exudative age-related macular degeneration.
Jonas JB; Libondi T; Golubkina L; Spandau UH; Schlichtenbrede F; Rensch F
Acta Ophthalmol; 2010 Sep; 88(6):630-4. PubMed ID: 19432871
[TBL] [Abstract][Full Text] [Related]
49. Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation.
Freund KB; Klais CM; Eandi CM; Ober MD; Goldberg DE; Sorenson JA; Yannuzzi LA
Arch Ophthalmol; 2006 Apr; 124(4):487-92. PubMed ID: 16606873
[TBL] [Abstract][Full Text] [Related]
50. Intravitreal triamcinolone acetonide for the treatment of immune recovery uveitis macular edema.
Morrison VL; Kozak I; LaBree LD; Azen SP; Kayicioglu OO; Freeman WR
Ophthalmology; 2007 Feb; 114(2):334-9. PubMed ID: 17270681
[TBL] [Abstract][Full Text] [Related]
51. One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion.
Gregori NZ; Rosenfeld PJ; Puliafito CA; Flynn HW; Lee JE; Mavrofrides EC; Smiddy WE; Murray TG; Berrocal AM; Scott IU; Gregori G
Retina; 2006 Oct; 26(8):889-95. PubMed ID: 17031288
[TBL] [Abstract][Full Text] [Related]
52. Intravitreal triamcinolone acetonide for treatment of acute nonarteritic anterior ischemic optic neuropathy.
Jonas JB; Spandau UH; Harder B; Sauder G
Graefes Arch Clin Exp Ophthalmol; 2007 May; 245(5):749-50. PubMed ID: 16673138
[TBL] [Abstract][Full Text] [Related]
53. Spectral-domain optical coherence tomography of sympathetic ophthalmia with Dalen-Fuchs nodules.
Muakkassa NW; Witkin AJ
Ophthalmic Surg Lasers Imaging Retina; 2014; 45(6):610-2. PubMed ID: 25347826
[TBL] [Abstract][Full Text] [Related]
54. Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion.
Bashshur ZF; Ma'luf RN; Allam S; Jurdi FA; Haddad RS; Noureddin BN
Arch Ophthalmol; 2004 Aug; 122(8):1137-40. PubMed ID: 15302653
[TBL] [Abstract][Full Text] [Related]
55. Intravitreal injections of triamcinolone acetonide for severe vitritis in patients with incomplete Behcet's disease.
Kramer M; Ehrlich R; Snir M; Friling R; Mukamel M; Weinberger D; Axer-Siegel R
Am J Ophthalmol; 2004 Oct; 138(4):666-7. PubMed ID: 15488806
[TBL] [Abstract][Full Text] [Related]
56. Retinal capillary hemangioma treated with verteporfin photodynamic therapy and intravitreal triamcinolone acetonide.
Suh SC; Jin SY; Bae SH; Kim CG; Kim JW
Korean J Ophthalmol; 2007 Sep; 21(3):178-84. PubMed ID: 17804927
[TBL] [Abstract][Full Text] [Related]
57. Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone.
Larsson J; Zhu M; Sutter F; Gillies MC
Am J Ophthalmol; 2005 May; 139(5):802-6. PubMed ID: 15860283
[TBL] [Abstract][Full Text] [Related]
58. Intravitreal triamcinolone acetonide: a change in a paradigm.
Jonas JB
Ophthalmic Res; 2006; 38(4):218-45. PubMed ID: 16763379
[TBL] [Abstract][Full Text] [Related]
59. Early treatment of cystoid macular edema secondary to branch retinal vein occlusion with intravitreal triamcinolone acetonide.
Yepremyan M; Wertz FD; Tivnan T; Eversman L; Marx JL
Ophthalmic Surg Lasers Imaging; 2005; 36(1):30-6. PubMed ID: 15688969
[TBL] [Abstract][Full Text] [Related]
60. Comparison of intravitreal triamcinolone acetonide versus intravitreal bevacizumab as the primary treatment of clinically significant macular edema.
Liu Q; Hu Y; Yu H; Yuan L; Hu J; Atik A; Guan M; Li D; Li X; Tang S
Retina; 2015 Feb; 35(2):272-9. PubMed ID: 25105313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
